Dare Bioscience, Inc. Stock Split Ratio
Dare Bioscience, Inc. (DARE) had Stock Split Ratio of 8.33% as of 2024-07-01, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-03-26
- Dare Bioscience, Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2014-03-31 was 1450.74%.
- Dare Bioscience, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2020 was 10.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|---|
| 2024-07-01 | 8.33% 10-K · filed 2026-03-26 | |||||
| 2020-12-31 | 10.00% 10-K · filed 2021-03-30 | |||||
| 2017-07-20 | 10.00% 10-K · filed 2020-03-27 | |||||
| 2014-09-30 | 1450.74% 10-Q · filed 2014-11-13 | |||||
| 2014-06-30 | 1450.74% 10-Q · filed 2014-08-12 | |||||
| 2014-03-31 | 1450.74% 10-K · filed 2015-03-19 | 1450.74% 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |